Company Legal Name
Latest Valuation
Founded Year
Headquarters
Medable Inc. develops software platforms that enable pharmaceutical companies and research organizations to conduct decentralized and hybrid clinical trials through remote patient monitoring capabilities. Founded in 2015 and headquartered in Palo Alto, the company addresses the growing demand for flexible trial methodologies that reduce patient burden while maintaining data integrity and regulatory compliance. Medable's platform facilitates virtual patient engagement, real-world evidence collection, and streamlined trial operations across multiple therapeutic areas. The company serves biopharmaceutical companies, contract research organizations, and academic medical centers seeking to modernize their clinical research processes and improve patient accessibility to trials through digital-first approaches.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
